首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
- English Japanese Korean
首頁 > 市場調查報告書 > 製藥 > 製藥企業 > 歐洲製藥/生物技術的委託製造市場:策略展望
產業/市場分類
製藥 (4495)
肥胖症治療 (48)
非專利藥 (117)
疫苗 (168)
神經疾病 (175)
骨頭疾病治療 (41)
動物用醫藥 (18)
處方藥 (89)
規章 (107)
感染疾病 (318)
精神病 (80)
製藥企業 (506)
糖尿病 (157)
癌症 (838)
藥物開發 (1275)
DDS (173)
OTC 非處方藥 (147)
市場調查報告書

歐洲製藥/生物技術的委託製造市場:策略展望

European Pharma/Biotech Contract Manufacturing Markets: A Strategic Outlook

出版商 Frost & Sullivan
出版日期 2008年04月 商品編碼 65336
內容資訊 英文  
價格
US $ 6500 Web Access (Regional License)
US $ 7000 Hard Copy & Web Access (Regional License)


歐洲製藥/生物技術的委託製造市場:策略展望 是由出版商Frost & Sullivan在2008年04月所出版的。 這份英文市場調查報告書價格從美金6500起跳。

目錄

Abstract

This research service provides a strategic outlook of the pharma/Biotech contract manufacturing markets in Europe. It includes technology trends, challenges, drivers, restraints, competitive structure, strategic recommendations and list of market participants.

Table of Contents

1 EUROPEAN PHARMA/BIOTECH CONTRACT MANUFACTURING MARKETS, EXECUTIVE SUMMARY

  • Summary of Key Findings
    • Key Conclusions

2 EUROPEAN PHARMA/BIOTECH CONTRACT MANUFACTURING MARKETS, TOTAL EUROPEAN PHARMA/BIOTECH CONTRACT MANUFACTURING MARKET

  • Introduction
    • Outsourcing in the Pharma/Biotech Industry: There is no Alternative
    • The Role of CMOs in the Pharma/Biotech Industry
    • Scope and Segmentation
    • Market Overview
    • Technology Trends
  • Market Engineering Research
    • Industry Challenges
    • Market Drivers
    • Market Restraints
  • Competitive Analysis
    • Competitive Structure
    • Trends in the Biotech Contract Manufacturing Market

3 EUROPEAN PHARMA/BIOTECH CONTRACT MANUFACTURING MARKETS, STRATEGIC RECOMMENDATIONS

  • Strategic Recommendations
    • Recommendations to Market Participants

4 EUROPEAN PHARMA/BIOTECH CONTRACT MANUFACTURING MARKETS, DATABASE OF KEY INDUSTRY PARTICIPANTS

  • Key Industry Participants
    • DKIP

5 EUROPEAN PHARMA/BIOTECH CONTRACT MANUFACTURING MARKETS, DECISION SUPPORT DATABASES

  • Decision Support Databases
    • Government Investment in Biotechnology
    • Pharmaceutical R&D Expenditure
    • EPO Biotechnology Patents
Back to Top